Comirnaty®
The advice of the National Immunisation Advisory Committee is that evidence of efficacy of doses given before 17 days is lacking. However there is also no safety and efficacy date in relation to repeating vaccination in this situation (giving a total of 3 doses). Therefore a further dose is not required. This should be reported to HPRA and an incident report form completed.
If a dose is given between 17 and 21 days, this is considered a valid dose.
COVID‐19 Vaccine Moderna®
The advice of the National Immunisation Advisory Committee is that evidence of efficacy of doses given before 24 days is lacking . However there is also no safety and efficacy date in relation to repeating vaccination in this situation (giving a total of 3 doses). Therefore a further dose is not required. This should be reported to HPRA and an incident report form completed.
If a dose is given between 24 and 27 days, this is considered a valid dose.
COVID-19 Vaccine AstraZeneca®
The advice of the National Immunisation Advisory Committee is that evidence of efficacy of doses given before 24 days is lacking . However there is also no safety and efficacy date in relation to repeating vaccination in this situation (giving a total of 3 doses). Therefore a further dose is not required. This should be reported to HPRA and an incident report form completed.
If a dose is given between 24 and 27 days , this is considered a valid dose.